BUBCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。BUB遺伝子サイレンサーは、BUB CRISPR/Cas9ノックアウトプラスミドとBUBDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のBUBCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
BUB CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
BUB1 CRISPR/Cas9 KOプラスミド (h) | sc-402006 | h | Gene Knockout | GFP | 0 | ||
BUB1 HDRプラスミド (h) | sc-402006-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
BUB1 Double Nickaseプラスミド (h) | sc-402006-NIC | h | Gene Knockout | Puromycin | 0 | ||
BUB1 Double Nickaseプラスミド (h2) | sc-402006-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
BUB1 CRISPR/Cas9 KOプラスミド (m) | sc-419379 | m | Gene Knockout | GFP | 0 | ||
BUB1 HDRプラスミド (m) | sc-419379-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
BUB1 Double Nickaseプラスミド (m) | sc-419379-NIC | m | Gene Knockout | Puromycin | 0 | ||
BUB1 Double Nickaseプラスミド (m2) | sc-419379-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
BUB3 CRISPR/Cas9 KOプラスミド (h) | sc-402439 | h | Gene Knockout | GFP | 0 | ||
BUB3 HDRプラスミド (h) | sc-402439-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
BUB3 Double Nickaseプラスミド (h) | sc-402439-NIC | h | Gene Knockout | Puromycin | 0 | ||
BUB3 Double Nickaseプラスミド (h2) | sc-402439-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
BUB3 CRISPR/Cas9 KOプラスミド (m) | sc-419381 | m | Gene Knockout | GFP | 0 | ||
BUB3 HDRプラスミド (m) | sc-419381-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
BUB3 Double Nickaseプラスミド (m) | sc-419381-NIC | m | Gene Knockout | Puromycin | 0 | ||
BUB3 Double Nickaseプラスミド (m2) | sc-419381-NIC-2 | m | Gene Knockout | Puromycin | 0 |
BUB CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
BUB1 CRISPR Activationプラスミド (h) | sc-402006-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB1 CRISPR Activationプラスミド (h2) | sc-402006-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB1 Lentiviral Activation Particles (h) | sc-402006-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB1 Lentiviral Activation Particles (h2) | sc-402006-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB1 CRISPR Activationプラスミド (m) | sc-419379-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB1 CRISPR Activationプラスミド (m2) | sc-419379-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB1 Lentiviral Activation Particles (m) | sc-419379-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB1 Lentiviral Activation Particles (m2) | sc-419379-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB3 CRISPR Activationプラスミド (h) | sc-402439-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB3 CRISPR Activationプラスミド (h2) | sc-402439-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB3 Lentiviral Activation Particles (h) | sc-402439-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB3 Lentiviral Activation Particles (h2) | sc-402439-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB3 CRISPR Activationプラスミド (m) | sc-419381-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB3 CRISPR Activationプラスミド (m2) | sc-419381-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB3 Lentiviral Activation Particles (m) | sc-419381-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BUB3 Lentiviral Activation Particles (m2) | sc-419381-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |